Cargando…
Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
Autores principales: | Decool, Gauthier, Domenech, Carine, Grardel, Nathalie, Plesa, Adriana, Raczkiewicz, Imelda, Ducourneau, Benoit, Ruminy, Philippe, Pages, Marie-Pierre, Girard, Sandrine, Fenwarth, Laurène, Preudhomme, Claude, Bertrand, Yves, Duployez, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746024/ https://www.ncbi.nlm.nih.gov/pubmed/31723830 http://dx.doi.org/10.1097/HS9.0000000000000193 |
Ejemplares similares
-
Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia
por: Duployez, Nicolas, et al.
Publicado: (2015) -
ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer
por: Huang, Wei, et al.
Publicado: (2021) -
Association of ZC3HAV1 single nucleotide polymorphisms with the susceptibility of Vogt-Koyanagi-Harada Disease
por: Wu, Qiuying, et al.
Publicado: (2023) -
Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial
por: Fenwarth, Laurène, et al.
Publicado: (2020) -
circZC3HAV1 Regulates TBC1D9 to Affect the Biological Behavior of Colorectal Cancer Cells
por: Zhang, Jianxian, et al.
Publicado: (2022)